ReviewTherapeutic advances in medical oncology2022

Prognostic impact of body mass index (BMI) in HER2+ breast cancer treated with anti-HER2 therapies: from preclinical rationale to clinical implications.

Francesca Ligorio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.